| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de Calumet Specialty Products Partners, L.P.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.45 |
| 52 Week High | US$19.91 |
| 52 Week Low | US$11.91 |
| Beta | 1.76 |
| 1 Month Change | 0.52% |
| 3 Month Change | -10.49% |
| 1 Year Change | -8.58% |
| 3 Year Change | 164.10% |
| 5 Year Change | 228.72% |
| Change since IPO | -28.97% |
Noticias y actualizaciones recientes
Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist
Apr 01
Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]
Mar 18Recent updates
Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist
Apr 01Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]
Mar 18LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket
Feb 11Calumet Specialty Products: Falling Knifes And Investor Irrationality
Jan 29Calumet Specialty Products Blasted Off, The Cash Flow Went Solar
Aug 19Calumet Specialty Q2 2022 Earnings Preview
Aug 04The Final Countdown For Calumet Specialty Products' Launch Continues
Jul 29It's The Final Countdown For Calumet Specialty Products
May 16Calumet Specialty Products Partners, L.P. Always Landing On Its Feet
Mar 07Evaluating Calumet's Apparent Conservative Equity Valuation
Jan 28Calumet Specialty Products Calls All Aboard
Dec 08Frantic Buying At Calumet Specialty Products
Oct 21For Calumet, Progress Marches
Sep 01More About Calumet's Duo Threaded Growth Businesses
Jun 16Calumet Specialty EPS misses by $1.25, beats on revenue
May 07Calumet's Critical Fundaments Continue To Improve, Significantly
Jan 30Calumet makes Borgmann permanent CFO, lifting interim role
Jan 07Calumet Specialty EPS misses by $0.11, beats on revenue
Nov 06Navigating Calumet's Crossroads
Nov 02Rentabilidad de los accionistas
| CLMT | US Oil and Gas | Mercado US | |
|---|---|---|---|
| 7D | -5.3% | 0.3% | 1.0% |
| 1Y | -8.6% | 21.6% | 27.2% |
Rentabilidad vs. Industria: CLMT obtuvo unos resultados inferiores a los del sector US Oil and Gas , que el año pasado arrojó un rendimiento del 14.9%.
Rentabilidad vs. Mercado: CLMT obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| CLMT volatility | |
|---|---|
| CLMT Average Weekly Movement | 4.8% |
| Oil and Gas Industry Average Movement | 4.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: CLMT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CLMT (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1919 | 1,580 | Louis Borgmann | calumet.com |
Calumet Specialty Products Partners, L.P. fabrica, formula y comercializa una gama diversificada de productos de marcas especializadas y combustibles renovables para diversos mercados industriales y de consumo en Norteamérica e internacionalmente. Opera a través de los segmentos Specialty Products and Solutions; Performance brands; Montana/Renewables; y Corporate. El segmento Specialty Products and Solutions ofrece diversos disolventes, ceras, aceites lubricantes personalizados, aceites blancos, petrolatos, geles, ésteres y otros productos.
Resumen de fundamentos de Calumet Specialty Products Partners, L.P.
| Estadísticas fundamentales de CLMT | |
|---|---|
| Capitalización bursátil | US$1.22b |
| Beneficios(TTM) | -US$11.90m |
| Ingresos (TTM) | US$4.15b |
0.3x
Ratio precio-ventas (PS)-104.2x
Ratio precio-beneficio (PE)¿Está CLMT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CLMT | |
|---|---|
| Ingresos | US$4.15b |
| Coste de los ingresos | US$3.73b |
| Beneficio bruto | US$416.20m |
| Otros gastos | US$428.10m |
| Beneficios | -US$11.90m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.15 |
| Margen bruto | 10.03% |
| Margen de beneficio neto | -0.29% |
| Ratio deuda/patrimonio | -752.4% |
¿Cómo se ha desempeñado CLMT a largo plazo?
Ver rendimiento histórico y comparativa